Skip to main content
SpringerLink
Log in

HIV-Associated Lymphomas

  • Chapter
  • First Online:
Rare Lymphomas

Part of the book series: Hematologic Malignancies ((HEMATOLOGIC))

  • 1105 Accesses

Abstract

Different types of lymphoproliferations have been recognized in the setting of human immunodeficiency virus (HIV) infection. These lesions comprise HIV-related lymphoid hyperplasia of various kind and overt malignant lymphomas. Lymphomas arising in the setting of HIV infection have been subclassified based on their occurrence in immunocompromised individuals, in the setting of HIV exclusively, and those occurring in immunocompetent individuals as well (Raphael M, In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, 2008a).

Pathology: German Ott and Eric D. Hsi

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Andrieu JM, Roithmann S, Tourani JM, Levy R, Desablens B, le Maignan C et al (1993) Hodgkin’s disease during HIV1 infection: the French registry experience. French Registry of HIV-associated Tumors. Ann Oncol 4(8):635–641

    CAS  PubMed  Google Scholar 

  • Ballerini P, Gaidano G, Gong J, Tassi V, Saglio G, Knowles DM et al (1992) Molecular pathogenesis of HIV-associated lymphomas. AIDS Res Hum Retroviruses 8(5):731–735

    CAS  PubMed  Google Scholar 

  • Barnes JA, Lacasce AS, Feng Y, Toomey CE, Neuberg D, Michaelson JS et al (2011) Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt’s lymphoma: a retrospective analysis. Ann Oncol 22(8):1859–1864

    Article  CAS  PubMed  Google Scholar 

  • Berenguer J, Miralles P, Ribera JM, Rubio R, Valencia E, Mahillo B et al (2008) Characteristics and outcome of AIDS-related Hodgkin lymphoma before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 47(4):422–428

    Article  CAS  PubMed  Google Scholar 

  • Bi J, Espina BM, Tulpule A, Boswell W, Levine AM (2001) High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin’s lymphoma. J Acquir Immune Defic Syndr 28(5):416–421

    Article  CAS  PubMed  Google Scholar 

  • Bibas M, Grisetti S, Alba L, Picchi G, Del Nonno F, Antinori A (2010) Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone. J Clin Oncol 28(34):e704–e708

    Article  PubMed  Google Scholar 

  • Bishop PC, Rao VK, Wilson WH (2000) Burkitt’s lymphoma: molecular pathogenesis and treatment. Cancer Invest 18(6):574–583

    Article  CAS  PubMed  Google Scholar 

  • Boue F, Gabarre J, Gisselbrecht C, Reynes J, Cheret A, Bonnet F et al (2006) Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin’s lymphoma. J Clin Oncol 24(25):4123–4128

    Article  CAS  PubMed  Google Scholar 

  • Boulanger E, Daniel MT, Agbalika F, Oksenhendler E (2003) Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma. Am J Hematol 73(3):143–148

    Article  CAS  PubMed  Google Scholar 

  • Boulanger E, Gerard L, Gabarre J, Molina JM, Rapp C, Abino JF et al (2005) Prognostic factors and outcome of human herpes virus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 23(19):4372–4380

    Article  PubMed  Google Scholar 

  • Carbone A, Gloghini A (2005) AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 130(5):662–670

    Article  CAS  PubMed  Google Scholar 

  • Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C et al (2010) Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma 51(11):2047–2053

    Article  PubMed  Google Scholar 

  • Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM (2004) KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 28(11):1401–1416

    Article  PubMed  Google Scholar 

  • Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH et al (2009) Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol 27(30):5039–5048

    Article  PubMed  Google Scholar 

  • Chimienti E, Spina M, Gastaldi R, et al (2008) Clinical characteristics and outcome of 290 patients with Hodgkin’s disease and HIV infection (HD-HIV) in pre and HAART (highly active antiretroviral therapy) era. Ann Oncol 19: iv136, abs 168

    Google Scholar 

  • Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235–242

    Article  CAS  PubMed  Google Scholar 

  • Cortes J, Thomas D, Rios A, Koller C, O’Brien S, Jeha S et al (2002) Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer 94(5):1492–1499

    Article  CAS  PubMed  Google Scholar 

  • Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ et al (2006) Molecular diagnosis of Burkitt’s lymphoma. N Engl J Med 354(23):2431–2442

    Article  CAS  PubMed  Google Scholar 

  • Davi F, Delecluse HJ, Guiet P, Gabarre J, Fayon A, Gentilhomme O et al (1998) Burkitt-like lymphomas in AIDS patients: characterization within a series of 103 human immunodeficiency virus-associated non-Hodgkin’s lymphomas. Burkitt’s Lymphoma Study Group. J Clin Oncol 16(12):3788–3795

    CAS  PubMed  Google Scholar 

  • Davis RE, Ngo VN, Lenz G, Tolar P, Young RM, Romesser PB et al (2010) Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma. Nature 463(7277):88–92

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U et al (1997) Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 89(4):1413–1420

    CAS  PubMed  Google Scholar 

  • Dunleavy K, Wilson WH (2010) Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphoma. J Clin Oncol 28(16):e260; author reply e61-2

    Article  PubMed  Google Scholar 

  • Dunleavy K, Wilson WH, Kaplan LD (2006) The case for rituximab in AIDS-related lymphoma. Blood 107(7):3014–3015

    Article  CAS  PubMed  Google Scholar 

  • Dunleavy K, Pittaluga S, Czuczman MS, Dave SS, Wright G, Grant N et al (2009) Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma. Blood 113(24):6069–6076

    Article  CAS  PubMed  Google Scholar 

  • Dunleavy K, Little RF, Pittaluga S, Grant N, Wayne AS, Carrasquillo JA et al (2010a) The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma. Blood 115(15):3017–3024

    Article  CAS  PubMed  Google Scholar 

  • Dunleavy K, Mikhaeel G, Sehn LH, Hicks RJ, Wilson WH (2010b) The value of positron emission tomography in prognosis and response assessment in non-Hodgkin lymphoma. Leuk Lymphoma 51(Suppl 1):28–33

    Article  PubMed  Google Scholar 

  • Dunleavy K, Pittaluga S, Wayne A, Shovlin M, Johnson J, Little R, et al (2011) MYC + Aggressive B-cell lymphomas: Novel therapy of untreated Burkitt lymphoma (BL) and MYC + Diffuse Large B-cell lymphoma (DLBCL) with DA-EPOCH-R. Ann Oncol 22(suppl 4):Abstract 071

    Google Scholar 

  • Errante D, Tirelli U, Gastaldi R, Milo D, Nosari AM, Rossi G et al (1994) Combined antineoplastic and antiretroviral therapy for patients with Hodgkin’s disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT). Cancer 73(2):437–444

    Article  CAS  PubMed  Google Scholar 

  • Errante D, Gabarre J, Ridolfo AL, Rossi G, Nosari AM, Gisselbrecht C et al (1999) Hodgkin’s disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF. Ann Oncol 10(2):189–195

    Article  CAS  PubMed  Google Scholar 

  • Fisher RI, Gaynor ER, Dahlberg S, Oken MM, Grogan TM, Mize EM et al (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin’s lymphoma. N Engl J Med 328(14):1002–1006

    Article  CAS  PubMed  Google Scholar 

  • Gabarre J, Marcelin AG, Azar N, Choquet S, Levy V, Levy Y et al (2004) High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica 89(9):1100–1108

    PubMed  Google Scholar 

  • Gastaldi R, Martino P, Gentile G, Picardi V, De Propris MS, Pirillo MF et al (2002) Hodgkin’s disease in HIV-infected patients: report of eight cases usefully treated with doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD) plus granulocyte colony- stimulating factor. Ann Oncol 13(7):1158–1160

    Article  CAS  PubMed  Google Scholar 

  • Ghosh SK, Wood C, Boise LH, Mian AM, Deyev VV, Feuer G et al (2003) Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-kappa B. Blood 101(6):2321–2327

    Article  CAS  PubMed  Google Scholar 

  • Grulich AE, Wan X, Law MG, Milliken ST, Lewis CR, Garsia RJ et al (2000) B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin’s lymphoma in people with AIDS. AIDS 14(2):133–140

    Article  CAS  PubMed  Google Scholar 

  • Hartmann P, Rehwald U, Salzberger B, Franzen C, Sieber M, Wohrmann A et al (2003) BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection. Ann Oncol 14(10):1562–1569

    Article  CAS  PubMed  Google Scholar 

  • Hegde U, Filie A, Little RF, Janik JE, Grant N, Steinberg SM et al (2005) High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood 105(2):496–502

    Article  CAS  PubMed  Google Scholar 

  • Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, Plettenberg A et al (2001) Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15(16):2119–2127

    Article  CAS  PubMed  Google Scholar 

  • Johnson N, Parkin JM (1998) Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis. Clin Exp Immunol 113(2):229–234

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Kaplan LD, Abrams DI, Feigal E, McGrath M, Kahn J, Neville P et al (1989) AIDS-associated non-Hodgkin’s lymphoma in San Francisco. JAMA 261(5):719–724

    Article  CAS  PubMed  Google Scholar 

  • Kaplan LD, Straus DJ, Testa MA, Von Roenn J, Dezube BJ, Cooley TP et al (1997) Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin’s lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 336(23):1641–1648

    Article  CAS  PubMed  Google Scholar 

  • Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A et al (2005) Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010. Blood 106(5):1538–1543

    Article  CAS  PubMed  Google Scholar 

  • Krishnan A, Molina A, Zaia J, Smith D, Vasquez D, Kogut N et al (2005) Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 105(2):874–878

    Article  CAS  PubMed  Google Scholar 

  • Lester R, Li C, Phillips P, Shenkier TN, Gascoyne RD, Galbraith PF et al (2004) Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma 45(9):1881–1885

    Article  PubMed  Google Scholar 

  • Levine AM, Li P, Cheung T, Tulpule A, Von Roenn J, Nathwani BN et al (2000) Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin’s disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). J Acquir Immune Defic Syndr 24(5):444–450

    Article  CAS  PubMed  Google Scholar 

  • Lim ST, Levine AM (2005) Recent advances in acquired immunodeficiency syndrome (AIDS)-related lymphoma. CA Cancer J Clin 55(4):229–241;60–61, 64

    Article  PubMed  Google Scholar 

  • Lim ST, Karim R, Nathwani BN, Tulpule A, Espina B, Levine AM (2005) AIDS-related Burkitt’s lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 23(19):4430–4438

    Article  CAS  PubMed  Google Scholar 

  • Ling SM, Roach M 3rd, Larson DA, Wara WM (1994) Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California San Francisco. Cancer 73(10):2570–2582

    Article  CAS  PubMed  Google Scholar 

  • Little RF, Pittaluga S, Grant N, Steinberg SM, Kavlick MF, Mitsuya H et al (2003) Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 101(12):4653–4659

    Article  CAS  PubMed  Google Scholar 

  • Mounier N, Spina M, Gabarre J, Raphael M, Rizzardini G, Golfier JB et al (2006) AIDS-related non-Hodgkin lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood 107(10):3832–3840

    Article  CAS  PubMed  Google Scholar 

  • Neri A, Barriga F, Inghirami G, Knowles DM, Neequaye J, Magrath IT et al (1991) Epstein-Barr virus infection precedes clonal expansion in Burkitt’s and acquired immunodeficiency syndrome-associated lymphoma. Blood 77(5):1092–1095

    CAS  PubMed  Google Scholar 

  • Noy A, Kaplan L, Lee J (2009) Feasibility and toxicity of a modified dose intensive R-CODOX-M/IVAC for HIV-associated Burkitt and atypical Burkitt lymphoma (BL): preliminary results of a Prospective Multicenter Phase II Trial of the AIDS Malignancy Consortium (AMC). ASH Annu Meet Abstr 114:3673

    Google Scholar 

  • Phenix BN, Angel JB, Mandy F, Kravcik S, Parato K, Chambers KA et al (2000) Decreased HIV-associated T cell apoptosis by HIV protease inhibitors. AIDS Res Hum Retroviruses 16(6):559–567

    Article  CAS  PubMed  Google Scholar 

  • Raphael M, Gentilhomme O, Tulliez M, Byron PA, Diebold J (1991) Histopathologic features of high-grade non-Hodgkin’s lymphomas in acquired immunodeficiency syndrome. The French Study Group of pathology for human immunodeficiency virus-associated tumors. Arch Pathol Lab Med 115(1):15–20

    CAS  PubMed  Google Scholar 

  • Raphael M, Said J, Borisch B, Cesarman E, Harris N (2008) Lymphoma associated with HIV infection. In: Swerdlow SH et al (eds) WHO Classification of tumours of haematopoietic and lymphoid tissues, 4th edn. IARC, Lyon

    Google Scholar 

  • Ratner L, Lee J, Tang S, Redden D, Hamzeh F, Herndier B et al (2001) Chemotherapy for human immunodeficiency virus-associated non-Hodgkin’s lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19(8):2171–2178

    CAS  PubMed  Google Scholar 

  • Re A, Cattaneo C, Michieli M, Casari S, Spina M, Rupolo M et al (2003) High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 21(23):4423–4427

    Article  CAS  PubMed  Google Scholar 

  • Re A, Michieli M, Casari S, Allione B, Cattaneo C, Rupolo M et al (2009) High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors. Blood 114(7):1306–1313

    Article  CAS  PubMed  Google Scholar 

  • Ribera JM, Oriol A, Morgades M, Gonzalez-Barca E, Miralles P, Lopez-Guillermo A et al (2008) Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Br J Haematol 140(4):411–419

    CAS  PubMed  Google Scholar 

  • Rubio R (1994) Hodgkin’s disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid. Cancer 73(9):2400–2407

    Article  CAS  PubMed  Google Scholar 

  • Said J (2011) Hematopathology of human immunodeficiency virus infection. In: Jaffe ES et al (eds) Hematopathology. Saunders/Elsevier, Philadelphia

    Google Scholar 

  • Said J, Cesarman E et al (2008) Primary effusion lymphoma. In: Swerdlow SH (ed) WHO Classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon

    Google Scholar 

  • Serrano D, Carrion R, Balsalobre P, Miralles P, Berenguer J, Buno I et al (2005) HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol 33(4):487–494

    Article  CAS  PubMed  Google Scholar 

  • Shibata D, Weiss LM, Nathwani BN, Brynes RK, Levine AM (1991) Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin’s lymphoma. Blood 77(7):1527–1533

    CAS  PubMed  Google Scholar 

  • Shibata D, Weiss LM, Hernandez AM, Nathwani BN, Bernstein L, Levine AM (1993) Epstein-Barr virus-associated non-Hodgkin’s lymphoma in patients infected with the human immunodeficiency virus. Blood 81(8):2102–2109

    CAS  PubMed  Google Scholar 

  • Sparano JA, Lee S, Chen MG, Nazeer T, Einzig A, Ambinder RF et al (2004) Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin’s lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). J Clin Oncol 22(8):1491–1500

    Article  CAS  PubMed  Google Scholar 

  • Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF et al (2010) Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood 115(15):3008–3016

    Article  CAS  PubMed  Google Scholar 

  • Spina M, Vaccher E, Nasti G, Tirelli U (2000) Human immunodeficiency virus-associated Hodgkin’s disease. Semin Oncol 27(4):480–488

    CAS  PubMed  Google Scholar 

  • Spina M, Vaccher E, Juzbasic S, Milan I, Nasti G, Talamini R et al (2001) Human immunodeficiency virus-related non-Hodgkin lymphoma: activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients. Cancer 92(1):200–206

    Article  CAS  PubMed  Google Scholar 

  • Spina M, Gabarre J, Rossi G, Fasan M, Schiantarelli C, Nigra E et al (2002) Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood 100(6):1984–1988

    Article  CAS  PubMed  Google Scholar 

  • Spina M, Jaeger U, Sparano JA, Talamini R, Simonelli C, Michieli M et al (2005) Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials. Blood 105(5):1891–1897

    Article  CAS  PubMed  Google Scholar 

  • Spina M, Rossi G, Antinori A et al (2008) VEBEP regimen and highly active antiretroviral therapy (HAART) in patients (pts) with HD and HIV infection (HD-HIV). Ann Oncol 19:iv152, abs 227

    Google Scholar 

  • Spitzer TR, Ambinder RF, Lee JY, Kaplan LD, Wachsman W, Straus DJ et al (2008) Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant 14(1):59–66

    Article  CAS  PubMed  Google Scholar 

  • Subar M, Neri A, Inghirami G, Knowles DM, Dalla-Favera R (1988) Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 72(2):667–671

    CAS  PubMed  Google Scholar 

  • Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. IARC, Lyon

    Google Scholar 

  • Teruya-Feldstein J, Chiao E, Filippa DA, Lin O, Comenzo R, Coleman M et al (2004) CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15(11):1673–1679

    Article  CAS  PubMed  Google Scholar 

  • Tirelli U, Vaccher E, Serraino D, Bertola G, Saracchini S, Volpe R et al (1987) Comparison of presenting clinical and laboratory findings of patients with persistent generalized lymphadenopathy (PGL) syndrome and malignant lymphoma (ML). Haematologica 72(6):563–565

    CAS  PubMed  Google Scholar 

  • Tirelli U, Errante D, Dolcetti R, Gloghini A, Serraino D, Vaccher E et al (1995) Hodgkin’s disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 13(7):1758–1767

    CAS  PubMed  Google Scholar 

  • Vaccher E, Spina M, di Gennaro G, Talamini R, Nasti G, Schioppa O et al (2001) Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma. Cancer 91(1):155–163

    Article  CAS  PubMed  Google Scholar 

  • Vaccher E, Spina M, Talamini R, Zanetti M, di Gennaro G, Nasti G et al (2003) Improvement of systemic human immunodeficiency virus-related non-Hodgkin lymphoma outcome in the era of highly active antiretroviral therapy. Clin Infect Dis 37(11):1556–1564

    Article  PubMed  Google Scholar 

  • Xicoy B, Ribera JM, Miralles P, Berenguer J, Rubio R, Mahillo B et al (2007) Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin’s lymphoma. Haematologica 92(2):191–198

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Cancer Institute, Bethesda, MD, USA

    Kieron Dunleavy MD

  2. Department of Clinical Pathology, Robert-Bosch-Krankenhaus, Stuttgart, Germany

    German Ott MD

  3. Department of Clinical Pathology, Cleveland Clinic, L11, 9500 Euclid Ave, Cleveland, OH, 44195, USA

    Eric D. Hsi MD

  4. Division of Medical Oncology A, National Cancer Institute, Aviano, Italy

    Michele Spina MD

Authors
  1. Kieron Dunleavy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. German Ott MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eric D. Hsi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michele Spina MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Kieron Dunleavy MD .

Editor information

Editors and Affiliations

  1. Medizinischen Klinik und Poliklinik III, Universität München Klinikum Großhadern, München, Germany

    Martin Dreyling

  2. Division of Hematology/Oncology and Cancer Center, University of Virginia Health System, Charlottesville, Virginia, USA

    Michael E. Williams

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dunleavy, K., Ott, G., Hsi, E.D., Spina, M. (2014). HIV-Associated Lymphomas. In: Dreyling, M., Williams, M. (eds) Rare Lymphomas. Hematologic Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-39590-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-39590-1_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-39589-5

  • Online ISBN: 978-3-642-39590-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation